increasing incidence of intracranial aneurysms is driving the Flow Diversion Aneurysm Treatment Market
Technavio analyzes that the Flow Diversion Aneurysm Treatment Market is expected to grow at a CAGR of 9.34% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 2436.9 million.There are various factors that contribute to the growth of the market. The incidence of intracranial aneurysms, a condition characterized by the bulging of blood vessels in the brain, is on the rise, leading to a significant demand for effective treatment modalities. Among these, Flow Diversion Aneurysm Treatment has emerged as a promising solution. This minimally invasive procedure involves the use of a flow diversion device to redirect blood flow away from the aneurysm, thereby promoting thrombosis and eventual aneurysm obliteration. The global Flow Diversion Aneurysm Treatment Market is anticipated to grow at a robust pace due to the increasing prevalence of intracranial aneurysms and the advantages offered by this innovative treatment approach.
Flow diverting stents, or specialized endovascular devices, are utilized in the neurointerventional treatment of intracranial aneurysms. These aneurysms, which are weakened areas in the blood arteries of the brain, can potentially rupture and cause subarachnoid hemorrhages, a life-threatening condition. Flow diverters, such as flow diverting stents, redirect blood flow away from the aneurysm, encouraging the formation of a clot and ultimately leading to its healing and occlusion. Distinct from traditional stents, these therapeutic methods employ advanced flow diversion devices to effectively address complex and wide-necked intracranial aneurysms.
Know which region is leading the market growth by requesting a sample report
Flow Diversion Aneurysm Treatment Market Segmentation
As per our research findings, here are some of the key competitors that are leading the industry
Find out what is trending in the market by accessing the free PDF report
The Flow Diversion Aneurysm Treatment Market refers to the segment offering therapeutic approaches for intracranial aneurysms using endovascular techniques. These methods involve rerouting blood flow in ruptured and unruptured aneurysms, particularly in the posterior circulation, by deploying flow diversion devices like the Silk flow diverter, Pipeline embolization device, and Surpass flow diverter. Hospitals and specialty clinics provide neurointerventional procedures for aneurysm occlusion, catering to the growing need for minimally invasive treatments due to the global aging demographic and the healthcare burden. Skilled neurointerventionalists utilize these devices to preserve the parent blood vessel and redirect blood flow, making flow diversion procedures an essential part of specialized neurointerventional care, surpassing traditional surgical interventions in cerebral anatomy.
The Flow Diversion Aneurysm Treatment Market is a significant segment within the global pharmaceuticals industry, focusing on companies and research organizations involved in the development and production of therapeutic solutions for intracranial aneurysms. This market's growth is driven by the increasing prevalence of ruptured aneurysms, particularly in the elderly population. Technavio's market analysis identifies the aging population as a primary growth factor, with Europe and North America projected to reach over 25% senior citizens by 2030 and 2050, respectively. This demographic trend increases the demand for advanced endovascular techniques, such as flow diversion, to treat aneurysms in the parent blood vessel and maintain optimal blood flow in the posterior circulation.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
